| 000 | 01702 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518013639.0 | ||
| 264 | 0 | _c20190610 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-018-3587-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamasaki, Satoshi | |
| 245 | 0 | 0 |
_aImpact of hematopoietic stem cell transplantation in patients with relapsed or refractory marginal zone lymphoma. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cJun 2019 |
||
| 300 |
_a1521-1523 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAllografts |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, B-Cell, Marginal Zone _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aChihara, Dai | |
| 700 | 1 | _aYoshida, Isao | |
| 700 | 1 | _aKohda, Kyuhei | |
| 700 | 1 | _aSawa, Masashi | |
| 700 | 1 | _aAgo, Hiroatsu | |
| 700 | 1 | _aTogitani, Kazuto | |
| 700 | 1 | _aOhno, Yuju | |
| 700 | 1 | _aTanaka, Junji | |
| 700 | 1 | _aFukuda, Takahiro | |
| 700 | 1 | _aAtsuta, Yoshiko | |
| 700 | 1 | _aSuzumiya, Junji | |
| 700 | 1 | _aSuzuki, Ritsuro | |
| 773 | 0 |
_tAnnals of hematology _gvol. 98 _gno. 6 _gp. 1521-1523 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-018-3587-z _zAvailable from publisher's website |
| 999 |
_c29173262 _d29173262 |
||